The patient¿s attorney alleged a deficiency against the device.
The product was used for therapeutic treatment of an incarcerated abdominal incisional hernia.
It was reported that after underlay implant, the patient experienced severe pain, hernia recurrence, inflammation, meshoma, infection, dense adhesions, enterocutaneous fistula, scarring, abdominal wall cellulitis, draining sinus, necrotic tissue, and mesh eroding into small bowel.
Post-operative patient treatment included debridement and removal surgery.
|